RESUMO
Fungal cytochrome P450 enzymes have been shown to catalyze regio- and stereoselective oxidative intermolecular phenol coupling. However, an enzyme capable of catalyzing undirected para-para (C4-4') coupling has not been reported. Here, we revealed the biosynthetic gene cluster (BGC) of phomoxanthone A from the marine fungus Diaporthe sp. SYSU-MS4722. We heterologously expressed 14 biosynthetic genes in Aspergillus oryzae NSAR1 and found that PhoCDEFGHK is involved in the early stage of phomoxanthone A biosynthesis to give chrysophanol and that chrysophanol is then processed by PhoBJKLMNP to yield penexanthone B. A feeding experiment suggested that PhoO, a cytochrome P450 enzyme, catalyzed the regioselective oxidative para-para coupling of penexanthone B to give phomoxanthone A. The mechanism of PhoO represents a novel enzymatic 4,4'-linkage dimerization method for tetrahydroxanthone formations, which would facilitate biosynthetic engineering of structurally diverse 4,4'-linked dimeric tetrahydroxanthones.
Assuntos
Vias Biossintéticas , Fenol , Sistema Enzimático do Citocromo P-450/metabolismo , Fenóis/metabolismo , XantonasRESUMO
Metastasis and chemoresistance indicate poor prognosis in patients with osteosarcoma (OS). In the present study, the expression level of microRNA(miR)487b3p in OS specimens and cell lines was found to be decreased, and the expression level of miR487b3p was associated with overall survival in patients with OS. The inhibition of miR487b3p stimulated OS cell migration and contributed to the development of chemoresistance. In contrast, the overexpression of miR487b3p significantly inhibited OS cell migration and enhanced the sensitivity of OS cells to doxorubicin treatment. In addition, the results from the present study revealed that the suppression of miR487b3p stimulates OS stemness, while the overexpression of miR487b3p suppresses OS stemness. Notably, in vivo experiments also revealed that the overexpression of miR487b3p inhibited cancer stem cell (CSC)induced tumor formation, and the combination treatment of miR487b3p and doxorubicin significantly inhibited CSCinduced tumor growth. Furthermore, miR487b3p exerts its anticancer role by targeting aldehyde dehydrogenase 1 family member A3 in OS. Taken together, the results from the present study suggests that miR487b3p is a tumor suppressor and that the overexpression of miR487b3p is a novel strategy to inhibit tumor metastasis and chemoresistance in OS.